GL1X · GenesisL1 explorer

MolNFT v1 · #112934 · protein

Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor

5A09: “Crystal structure of human neutrophil elastase in complex with a dihydropyrimidone inhibitor”. X-ray diffraction, 3 ligands (JJD, NAG, FUC), 1 pocket (best druggability 0.44). MolNFT v1 #112934 on GenesisL1: 3D structure, binding…

PDB
5A09
Type
protein
Length
218 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neutrophil elastase
EC
3.4.21.37
UniProt
P08246
Ligands
JJD, NAG, FUC
Pockets
1 · best druggability 0.44

Structure

x-ray diffraction · 1 distinct chain · 9% helix, 39% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANeutrophil elastase (EC 3.4.21.37)protein2189% helix, 39% strandP08246

Ligands and binding sites

  • JJD · 2-[(4R)-4-(4-cyanophenyl)-5-ethanoyl-6-methyl-2-oxidanylidene-1-[3-(trifluoromethyl)phenyl]-4H-pyrimidin-3-yl]ethanoic acid · ligand · chains A
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 3 copies · chains A
  • FUC · alpha-L-fucopyranose · sugar · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1830.440.8018empty

Modifications

Observed in the structure: 4 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • 5A09 · Crystal Structure of human neutrophil elastase in complex with a dihydropyrimidone… · the same entry in another collection · chain A against A, TM-score 1.00
  • P08246 · AlphaFold monomer V2.0 prediction for neutrophil elastase (P08246) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.